|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash (used in) provided by operating activities | |||||
| Depreciation and amortization | |||||
| Gain on sale of property and equipment | |||||
| Extinguishment of unamortized debt issuance costs | |||||
| Amortization of lease right-of-use assets | |||||
| Stock-based compensation | |||||
| Income from Paycheck Protection Program | |||||
| Deferred income tax expense (benefit) | |||||
| Return on investments, net of income from unconsolidated entities | |||||
| Contingent consideration revaluation | |||||
| Payments of contingent consideration | |||||
| Inventory and lot deposit impairment | |||||
| Other, net | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Lot deposits | |||||
| Other assets | |||||
| Mortgage loans held for sale | |||||
| Accounts payable and accrued liabilities | |||||
| Customer deposits | |||||
| Lease liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Proceeds from disposals of property and equipment | |||||
| Investments in unconsolidated entities | |||||
| Return of investments from unconsolidated entities | |||||
| Payments for acquisitions, net of cash acquired | |||||
| Deposits on pending acquisitions | |||||
| Purchase of investment securities | |||||
| Proceeds from sales and maturities of investment securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from senior unsecured notes | |||||
| Proceeds from revolving credit facility and other borrowings | |||||
| Repayments on revolving credit facility and other borrowings | |||||
| Proceeds from mortgage warehouse facilities | |||||
| Repayments on mortgage warehouse facilities | |||||
| Payments of debt issuance costs | |||||
| Proceeds from common stock issuance | |||||
| Proceeds from issuance of convertible preferred stock | |||||
| Payments of equity issuance costs | |||||
| Proceeds from borrowings related to consolidated inventory not owned | |||||
| Redemption of Series B preferred units | |||||
| Payments of preferred stock dividends | |||||
| Payments for common stock withheld for taxes | |||||
| Conversion of LLC units | |||||
| Contributions | |||||
| Repurchases of common stock | |||||
| Distributions to noncontrolling interests | |||||
| Payments of contingent consideration | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures of cash payments: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
| Supplemental disclosures of noncash activities: | |||||
| Noncash investing activities | |||||
| Noncontrolling interests issued in business combinations | |||||
| Accrued cash consideration for business combinations | |||||
| Total noncash financing activities | |||||
| Contingent consideration | |||||
| Leased assets obtained in exchange for new operating lease liabilities | |||||
| Total noncash investing activities | |||||
| Reconciliation of cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...